Clinical trial
Effect of Clopidogrel on Early Failure of Arteriovenous Fistulas for Hemodialysis
NCT03289520 is registered in ClinicalTrials.gov with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Clopidogrel on Early Failure of Arteriovenous Fistulas for Hemodialysis
- Lead sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 7, 2003
- Completion date
- June 18, 2007
- Enrollment
- 877 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
hemodialysis fistula thrombosis, kidney failure